Nuclear Receptors as New Perspective for the Management of Liver Diseases
To access this article, please choose from the options below
Conflicts of interest The authors disclose the following: Dr Trauner serves as advisor for Falk and Phenex; moreover, he received unrestricted research support from Falk and Intercept, and travel support from Roche and Gilead. Dr Halilbasic discloses no conflicts.
Funding Supported by grants P18613-B05, F3008-B05 from the Austrian Science Foundation and European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement HEALTH-F2-2009-241762 for the project FLIP (to MT).
PII: S0016-5085(11)00198-3
doi:10.1053/j.gastro.2011.02.044
© 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

